PIPE-505 is the first small molecule developed specifically for the treatment of sensorineural hearing loss (SNHL) associated with speech-in-noise impairment
Just published: Potential of Imaging and the role for AI in the management of COVID-19
IAG’s radiomics team headed by Dr. Faiq Shaikh has just published the first article that explores the role of Reporter Gene Imaging in the realm of translational medicine.
Proceeds to advance PIPE-505 in hearing loss and additional neuroregenerative programs focused on synaptogenesis, remyelination and axonal repair
In 2017, RBV Capital acquired an equity stake in an innovative UK-based company developing an asset for treating symptoms of multiple sclerosis